Early research (Phase 1)Active Not RecruitingNCT05277051What this trial is testingFirst-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid TumorsWho this might be right forNeoplasms GlaxoSmithKline 152
Not applicableStudy completedNCT02285361What this trial is testingGIOTRIF rPMS in Korean Patients With NSCLCWho this might be right forCarcinoma, Non-Small-Cell Lung Boehringer Ingelheim 1,272
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06747169What this trial is testingEfficacy and Safety of Sintilimab Combined with Nab-PP Plus Rh-endostatin in Locally Advanced/advanced and Recurrent Metastatic Squamous Non-small Cell Lung Cancer: a Single-arm, Multicenter Clinical StudyWho this might be right forSquamous Non-Small Cell Lung Cancer SqNSCLC Jian-Guo Zhou, MD, PhD 32
Early research (Phase 1)Not Yet RecruitingNCT07807956What this trial is testingAssess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsNon-Small Cell Lung CancerColorectal Cancer+6 more AbbVie 130
Post-approval studies (Phase 4)Looking for participantsNCT07405086What this trial is testingMorning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT StudyWho this might be right forAdvanced Biliary Tract CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hepatocellular Carcinoma+18 more OHSU Knight Cancer Institute 160
Testing effectiveness (Phase 2)Active Not RecruitingNCT06933329What this trial is testingZelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer BicycleTx Limited 73
Not applicableStudy completedNCT01614002What this trial is testingA Non Interventional Study With Doce Onkovis (Docetaxel) Utilized for the Treatment of CancerWho this might be right forCarcinoma Onkovis GmbH 371
Early research (Phase 1)Study completedNCT02635672What this trial is testingPhase I Dose Escalation Study for VIP152 in Patients With Advanced CancerWho this might be right forNeoplasms Vincerx Pharma, Inc. 110
Not applicableUnknownNCT00242983What this trial is testingQuality of Life in Patients Who Are Receiving Either Vinorelbine, Gemcitabine, and Docetaxel or Paclitaxel and Carboplatin for Advanced Non-Small Cell Lung CancerWho this might be right forLung Cancer National Hospital Organization Kinki-chuo Chest Medical Center
Testing effectiveness (Phase 2)Study completedNCT01042288What this trial is testingCarboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type NSCLCWho this might be right forNon-Small-Cell Lung Cancer SCRI Development Innovations, LLC 70
Testing effectiveness (Phase 2)Looking for participantsNCT07169734What this trial is testingInvestigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid TumorsWho this might be right forCervical Squamous Cell CarcinomaSquamous Non-small-cell Lung CancerColorectal Cancer+2 more Alentis Therapeutics AG 180
Testing effectiveness (Phase 2)Active Not RecruitingNCT04180371What this trial is testingStudy BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 ExpressionWho this might be right forAdvanced Solid Tumor Historically Known for High EphA2 ExpressionUrothelial CancerOvarian Cancer+4 more BicycleTx Limited 288
Testing effectiveness (Phase 2)Looking for participantsNCT06868836What this trial is testingPhase II Clinical Study of JS207 (PD-1/VEGF Bispecific Antibody) Combination Therapies in Patients With Driver Gene-Positive, Advanced Non-Small Cell Lung Cancer After Failure of TKI TherapyWho this might be right forNon-squamous Non-small Cell Lung Cancer Shanghai Junshi Bioscience Co., Ltd. 78
Testing effectiveness (Phase 2)Study completedNCT02328105What this trial is testingLCI-LUN-ABR-001: Carbo With Nab-Paclitaxel in Patients With Advanced NSCL CancerWho this might be right forLung Cancer Wake Forest University Health Sciences 11
Large-scale testing (Phase 3)Looking for participantsNCT06930794What this trial is testingVebreltinib and Platinum-Containing Double Agents in Subjects With MET-PositiveWho this might be right forNon-Small Cell Lung Cancer Beijing Pearl Biotechnology Limited Liability Company 300
Large-scale testing (Phase 3)Ended earlyNCT03515629What this trial is testingREGN2810 (Anti-PD-1 Antibody), Platinum-based Doublet Chemotherapy, and Ipilimumab (Anti-CTLA-4 Antibody) Versus Pembrolizumab Monotherapy in Patients With Lung CancerWho this might be right forNon-small Cell Lung Cancer Regeneron Pharmaceuticals 5
Testing effectiveness (Phase 2)UnknownNCT03810872What this trial is testingAn Explorative Study of Afatinib in the Treatment of Advanced Cancer Carrying an EGFR, a HER2 or a HER3 MutationWho this might be right forCancers Harbouring an EGFR Mutation, (Excluding Non-squamous Non- Small Cell Lung Cancer, a Registered Indication), a HER2 Mutation or a HER3 Mutation Universitair Ziekenhuis Brussel 87
Testing effectiveness (Phase 2)Study completedNCT02186847What this trial is testingChemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung CancerWho this might be right forAdenosquamous Lung CarcinomaBronchioloalveolar CarcinomaLarge Cell Lung Carcinoma+6 more NRG Oncology 170
Early research (Phase 1)Looking for participantsNCT07638891What this trial is testingHDM2020 in Patients With Advanced Sq-NSCLCWho this might be right forSquamous Non-small Cell Lung Cancer(NSCLC) Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 150
Testing effectiveness (Phase 2)Looking for participantsNCT06975410What this trial is testingClinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid TumorsWho this might be right forEGFR OverexpressionLocally Advanced Solid TumorMetastatic Solid Tumor Yuhan Corporation 80